A carregar...
Switching patients from preserved prostaglandin-analog monotherapy to preservative-free tafluprost
PURPOSE: Efficacy, tolerability and safety of the novel preservative-free prostaglandin tafluprost 0.0015% were investigated for the treatment of patients with glaucoma or ocular hypertension in a clinical setting. PATIENTS AND METHODS: Data were collected in a non-interventional, prospective, multi...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3104790/ https://ncbi.nlm.nih.gov/pubmed/21629567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S17876 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|